Evidence for Cerebrospinal Fluid Flow Through the Brain to Stagnate in Alzheimer's Disease
Key claim: Impaired cerebrospinal fluid flow through the glymphatic system reduces the clearance of neurotoxic protein aggregates, contributing to brain aging and Alzheimer’s disease progression.
Abstract
Cerebrospinal fluid flows through the brain and out into the body, particularly during sleep. One of the important functions of this drainage of cerebrospinal fluid is the removal of metabolic waste from brain tissue. This waste material includes the pathological protein aggregates implicated in the onset and progression of common neurodegenerative conditions, such as amyloid-β, α-synuclein, tau, and TDP-43. The primary paths of drainage are collectively known as the glymphatic system. Measure of glymphatic drainage decline with age, and are particularly negatively impacted in patients with Alzheimer’s disease and other neurodegenerative conditions. Impaired cerebrospinal fluid drainage is coming to be seen as an important component of the aging of the brain. Initial consideration has been given to approaches to treatment, and evidence exists for a […]
Why this matters
Impaired cerebrospinal fluid flow through the glymphatic system reduces the clearance of neurotoxic protein aggregates, contributing to brain aging and Alzheimer’s disease progression.